Researchers are excited about the medication , a novel dual agonist showing promising data in early trials for size loss . It acts by modulating two pathways : GLP-1 and GIP, which , when stimulated, https://lucywffg486570.aboutyoublog.com/51811697/a-new-hope-for-body-reduction